Merck’s antiviral Covid-19 pill for lower-income countries if the drug gets authorization by regulations. As per a statement released by the private foundation, it hasn’t determined how it will allocate the money but will use the funds to “support the range of activities required to develop and manufacture generic versions" of the drug molnupiravir.
The Gates Foundation says its funding is also intended to help ready regulatory, delivery and other pathways in order to make the pill more accessible if it becomes available.
However, Trevor Mundel, the president of the foundation’s global health program, believes the generic manufacturers won't ramp up their manufacturing unless they know there will be demand, and are likely to wait until